An Agent Not Well MET in Lung Cancer

Dr. Mark Kris reports on 2 studies on MET inhibition in NSCLC that underscore the importance of defining the patient population who would benefit from a targeted therapy.

Source: Medscape Pulmonary Medicine Podcast - July 14, 2014 Category: Respiratory Medicine Authors: Medscape Source Type: podcasts